Sridhar Kosaraju - May 24, 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol
TXG
Transactions as of
May 24, 2021
Transactions value $
-$241,746
Form type
4
Date filed
5/26/2021, 08:28 PM
Next filing
Jun 15, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$64K -400 -2.67% $160.05 14.6K May 24, 2021 See Footnote F1, F2, F3
transaction TXG Class A Common Stock Sale -$113K -700 -4.79% $161.15 13.9K May 24, 2021 See Footnote F1, F3, F4
transaction TXG Class A Common Stock Sale -$48.6K -300 -2.16% $162.05 13.6K May 24, 2021 See Footnote F1, F3, F5
transaction TXG Class A Common Stock Sale -$16.3K -100 -0.74% $163.04 13.5K May 24, 2021 See Footnote F1, F3
holding TXG Class A Common Stock 2.83K May 24, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust.
F2 This transaction was executed in multiple trades at prices ranging from $159.64 to $160.605. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 These shares are held by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust").
F4 This transaction was executed in multiple trades at prices ranging from $160.66 to $161.635. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $161.91 to $162.14. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.